DNA: Analysis of vaccine's reliability of China

Daily News and Analysis (DNA) hosted by Zee News Editor-in-Chief Sudhir Chaudhary, brings to you analysis of the top news of the day. Chinese biopharmaceutical company Sinovac Biotech claimed on Thursday that clinical trials for its potential COVID-19 vaccine will begin on teenagers and children at the end of the month, after drawing positive findings on adults. In this segment of DNA, we do an analysis of the vaccine's reliability.